Gold

A GLP - 1 RA Masterclass

Sydney, NSW

WHEN: Saturday 29 May 2021

WHERE: International Convention Centre, Sydney, 14 Darling Dr, Sydney NSW 2000

Click here to register

Registration and workshops are limited, please secure your place early to avoid disappointment.
Registrations close on Friday 14 May 2021.

Agenda

9:30 – 10:00 am

Arrivals, registration and morning tea

10:00 – 10:15 am

Primary care and type 2 diabetes management – Why are we here today?

10:15 – 10:45 am

Can we slow the progression of type 2 diabetes?

10:45 – 11:15 am

Panel discussion: Navigating the treatment options – What do the guidelines say?

11:15 – 11:30 am

Ask the experts: Q&A

11:30 – 12:00 pm

Deep dive into GLP-1 RAs – Same-same but different?

12:00 – 12:45 pm

Lunch

12:45 – 1:10 pm

Case-based workshop rotation 1*

1:10 – 1:35 pm

Case-based workshop rotation 2*

1:35 – 2:00 pm

Case-based workshop rotation 3*

2:00 – 2:30 pm

Panel discussion: Where to after metformin?

2:30 – 2:45 pm

Ask the experts: Q&A

2:45 – 3:00 pm

Recap of today’s learnings

3:00 pm

Afternoon tea and departures

Workshops

*You have the choice to attend 3 of the following 4 case-based workshops. Within the registration form you will be asked to select your preferred workshops as these session will be pre-allocated. Workshop capacities are limited, please register early to secure your preferred workshops.

1

Decisions, decisions – How do I know if my patient is right for a GLP-1 RA?

Discover which patients are suitable for GLP-1 RAs and Ozempic®, including discussion on the impact of potential comorbidities and safety considerations.

2

Striking up a conversation – What is best practice when starting a GLP-1 RA?

Gain practical advice on how to discuss starting a GLP-1 RA, address any potential injection barriers and manage side effects. Includes a hands-on demonstration of the Ozempic® pen.

3

Navigating treatment combinations – What to do and what not to do?

Understand when and how to use Ozempic® in combination with insulin and other type 2 diabetes agents. Includes PBS and safety considerations and use as replacement vs an add-on therapy.

4

Clinical curveballs – What would the expert do?

Determine the suitability of Ozempic® for more complex clinical cases including use in the elderly, and in those with renal/hepatic impairment or cardiovascular disease.

Speakers

Please find below the list of confirmed speakers that will present the plenary sessions and workshops. Further speakers to be confirmed, please check back regularly for updates.

A/Prof Roger Chen

Endocrinologist

View full profile
X

A/Prof Roger Chen

Endocrinologist

Dr Ramy Bishay

Endocrinologist

View full profile
X

Dr Ramy Bishay

Endocrinologist

A/Prof Sarah Glastras

Endocrinologist

Royal North Shore Hospital, Northern Sydney Endocrine Centre, Senior Lecturer University of Sydney

View full profile
X

A/Prof Sarah Glastras

Endocrinologist

Royal North Shore Hospital, Northern Sydney Endocrine Centre, Senior Lecturer University of Sydney

A/Prof Sarah Glastras is a clinician researcher who works as a Staff Specialist in Endocrinology at the Royal North Shore Hospital, Sydney and holds a conjoint appointment as an academic Senior Lecturer at the University of Sydney. She also consults in a busy private endocrinology practice in St Leonards. Dr Glastras completed her PhD studies in 2016 at the Kolling Institute of Medical Research, University of Sydney on the role of maternal obesity in predisposing offspring towards chronic disease, and continues foetal programming research as a NHMRC Early Career Fellow. In addition to her basic science research, she is involved in many clinical studies in the areas of diabetes and obesity, with a special interest in pregnancy. She is leading a clinical study investigating the role of biomarkers in predicting preeclampsia in women with type 1 diabetes in pregnancy, funded by a JDRF Mentored Clinician Researcher Fellowship and supported by Diabetes Australia. She chairs the Complex Medical Management in Pregnancy Working Group within the Northern Sydney Local Health District

A/Prof Jane Overland

Nurse Practitioner, Clinical Associate Professor at the University of Sydney

Total Diabetes Care

View full profile
X

A/Prof Jane Overland

Nurse Practitioner, Clinical Associate Professor at the University of Sydney

Total Diabetes Care

Irene Kopp

Nurse Practitioner and Credentialled Diabetes Educator, Diabetes Service

Nepean Blue Mountains Local Health District

View full profile
X

Irene Kopp

Nurse Practitioner and Credentialled Diabetes Educator, Diabetes Service

Nepean Blue Mountains Local Health District

Register NowClick here

Further Information

Parking

Self parking will be available onsite at the ICC Sydney, further information and instructions will be provided
in your confirmation email.  You will have the opportunity within the registration form to advise if you
wish to have parking arranged.   

COVID-19 Safety Measures

The Novo Nordisk Meeting Secretariat will work with venues and suppliers to ensure they have current COVID-19 safety procedures in place as per the state and federal recommendations, additional information is available here.

A number of measures have been put in place as part for government guidelines and restrictions as well as in line for COVID safety practices. Further information will be outlined in your registration confirmation, however, please do not hesitate to contact the Meeting Secretariat if you have any questions. Hand sanitiser and face masks will be available for attendees whilst a maximum of five attendees per table will be allowed.

Register NowClick here

Enquiries

For enquiries on your registration or more information about the program please contact us at:

Novo Nordisk Meeting Secretariat